Blue Jet Healthcare has filed draft red herring prospectus (DRHP) with the market regulator Securities and Exchange Board of India (SEBI) to raise as much as Rs 2,100 crore through an initial public offering (IPO).
Kotak Mahindra Capital Company, ICICI Securities, and J.P. Morgan India are the books running lead managers to the issue. The equity shares are proposed to be listed on BSE and NSE.
The Mumbai-based Blue Jet Healthcare, is a specialty pharmaceutical and healthcare ingredient and intermediate company, offering niche products targeted towards innovator pharmaceutical companies and multinational generic pharmaceutical companies.
